Emergent BioSolutions
EBS
#8034
Rank
HK$2.92 B
Marketcap
HK$56.62
Share price
-0.55%
Change (1 day)
28.12%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): HK$0.46 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are HK$0.64 Billion. In 2025 the company made an earning of HK$1.11 Billion, an increase over its 2024 earnings that were of -HK$0.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$0.46 B-58.61%
2025 HK$1.11 B-297.64%
2024 -HK$0.57 Billion-88.82%
2023 -HK$5.05 Billion242.73%
2022 -HK$1.48 Billion-153.8%
2021 HK$2.73 B-20.43%
2020 HK$3.43 B278.02%
2019 HK$0.90 B27.11%
2018 HK$0.71 B-27.12%
2017 HK$0.98 B17.21%
2016 HK$0.83 B0.45%
2015 HK$0.83 B73.51%
2014 HK$0.48 B41.36%
2013 HK$0.34 B35.2%
2012 HK$0.25 B0.4%
2011 HK$0.25 B-56.46%
2010 HK$0.57 B76.73%
2009 HK$0.32 B32.94%
2008 HK$0.24 B-5.62%
2007 HK$0.25 B
2005 HK$0.37 B269.89%
2004 HK$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$83.05 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$103.13 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$78.50 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$91.79 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$0.16 B-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.43 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.80 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel